GLDC (Glycine Decarboxylase)

Key enzyme in glycine cleavage system, associated with glycine encephalopathy and cancer metabolism

Gene Information Card

Symbol GLDC
Full Name Glycine Decarboxylase
Gene Type Protein coding
Chromosomal Location 9p24.1
NCBI Gene ID 2731 ncbi.nlm.nih.gov/gene/2731
Ensembl ID ENSG00000178445
UniProt ID P23378
OMIM ID 238300
HGNC ID 4313
Aliases GCSP, NKH, HYGN1

Description

The GLDC gene encodes the glycine decarboxylase (P-protein) component of the glycine cleavage system, a mitochondrial multienzyme complex that catalyzes the oxidative cleavage of glycine into carbon dioxide, ammonia, and a methylene group transferred to tetrahydrofolate. This enzyme is essential for glycine metabolism and one-carbon metabolism. Mutations in GLDC are a major cause of nonketotic hyperglycinemia (glycine encephalopathy), an autosomal recessive disorder characterized by accumulation of glycine in body fluids and severe neurological symptoms. Altered GLDC expression has also been implicated in cancer cell proliferation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Nonketotic hyperglycinemia (NKH) Loss-of-function mutations impair glycine cleavage, leading to toxic glycine accumulation in brain and plasma ClinVar, OMIM
Glycine encephalopathy Deficient GLDC activity disrupts mitochondrial glycine metabolism, causing severe neonatal hypotonia, seizures, and developmental delay OMIM #238300
Cancer (various types) Overexpression of GLDC in some tumors supports one-carbon metabolism and nucleotide synthesis, promoting cell proliferation COSMIC, literature

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 8.3 Medium
Brain 5.1 Low
Heart 3.2 Low
Lung 2.8 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 10.2 Hepatocellular carcinoma cell line
HEK293 6.7 Embryonic kidney cells
SH-SY5Y 4.5 Neuroblastoma cell line
A549 3.1 Lung carcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.169C>T (p.Arg57*) Nonsense Rare Loss of function, associated with NKH
c.1546G>A (p.Gly516Arg) Missense Rare Reduced enzyme activity, NKH
c.2320C>T (p.Arg774Cys) Missense Rare Impaired glycine cleavage, NKH
c.2965C>T (p.Arg989Trp) Missense Rare Pathogenic, NKH
Mutation functional classification

Loss of Function (LOF)

Most GLDC mutations in nonketotic hyperglycinemia are loss-of-function, reducing or abolishing glycine decarboxylase activity.

Gain of Function (GOF)

Not reported; gain-of-function mutations are not a known mechanism for GLDC.

Dominant Negative (DN)

Not reported; GLDC-associated disease is autosomal recessive, requiring biallelic loss-of-function.

Gene Ontology (GO)

• Glycine decarboxylase activity • Glycine cleavage system
• One-carbon metabolic process • Mitochondrion
• Pyridoxal phosphate binding

Pathways

Glycine
serine and threonine metabolism (KEGG: hsa00260)
One carbon pool by folate (KEGG: hsa00670)
Glycine cleavage system

Protein Summary

Glycine decarboxylase (P-protein) is a mitochondrial enzyme that catalyzes the first step of the glycine cleavage system, decarboxylating glycine and transferring the methylamine group to lipoic acid. The protein is a homodimer of approximately 105 kDa subunits, requiring pyridoxal phosphate as a cofactor. It plays a critical role in maintaining glycine homeostasis and providing one-carbon units for biosynthetic processes. Deficiency leads to severe neurological disease, while overexpression may support cancer cell growth.

Related Products

Product name Cat.No. Species Gene ID
GLDC Knockout HEK293 Cell Line EDJ-KQ4717 Human 2731 Details Get a Quote
GLDC Knockout A-549 Cell Line EDJ-KQ27440 Human 2731 Details Get a Quote
GLDC Knockout HCT 116 Cell Line EDJ-KQ27441 Human 2731 Details Get a Quote
GLDC Knockout HeLa Cell Line EDJ-KQ53354 Human 2731 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: